Associate Professor, Psychiatry, Ohio State University COM
Psychiatry
Jessica A. Hellings, MB BCH
Jessica Hellings practices Psychiatry. She studied medicine at University of Kansas School of Medicine. Jessica Hellings is a published doctor and has 31 publications published. The lastest was: 'Sertraline response in adults with mental retardation and autistic disorder.' Jessica Hellings accepts Medicare payments and is registered with Medicare.gov.
Publications
- Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
- Low Dose Loxapine: Neuromotor Side Effects and Tolerability in Autism Spectrum Disorders.
- Loxapine Add-on for Adolescents and Adults with Autism Spectrum Disorders and Irritability.
- Training of child and adolescent psychiatry fellows in Autism and intellectual disability.
- A Retrospective Study of Amitriptyline in Youth with Autism Spectrum Disorders.
- Assessment and treatment in autism spectrum Disorders: a focus on genetics and psychiatry.
- 12-year-old boy with a 4q35.2 microdeletion and involvement of MTNR1A, FAT1, and F11 genes.
- IL1RAPL1 gene deletion as a cause of X-linked intellectual disability and dysmorphic features.
- ANKRD11 gene deletion in a 17-year-old male.
- A clinical report and further delineation of the 14q32 deletion syndrome.
- An 18-year follow-up report on an infant with a duplication of 9q34.
- Overnight versus progressive conversion of multiple daily-dose divalproex to once-daily divalproex extended release: which strategy is better tolerated by adults with ...
- Much improved outcome with gabapentin-divalproex combination in adults with bipolar Disorders and developmental disabilities.
- A crossover study of risperidone in children, adolescents and adults with mental retardation.
- Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental Disorders.
- A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental Disorders.
- The overt aggression scale for rating aggression in outpatient youth with autistic Disorder: preliminary findings.
- Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis.
- Use of functional analysis methodology in the evaluation of medication effects.
- Multimodal evaluation of risperidone for destructive behavior: functional analysis, direct observations, rating scales, and psychiatric impressions.
- Psychopathology, GABA, and the Rubinstein-Taybi syndrome: a review and case study.
- SPECT brain imaging abnormalities in Attention deficit hyperactivity disorder.
- Self-injurious behavior and serotonin in Prader-Willi syndrome.
- Sertraline response in adults with mental retardation and autistic Disorder.
- Using the Diagnostic Assessment of the Severely Handicapped-II (DASH-II) to measure the therapeutic effects of risperidone.
- Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures.
- Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and Autism.
- Effects of risperidone on aberrant behavior in persons with developmental disabilities: II. Social validity measures.
- Efficacy and safety of selective serotonin reuptake inhibitors in the treatment of depression in children and adolescents: practitioner review.
- Genetics and mitochondrial abnormalities in autism spectrum Disorders: a review.
Schools
University of The WitwatersrandFaculty of Health Sciences
Johannesburg Hospital
University Kansas Med Center
Conditions Treated
- Attention Deficit Hyperactivity Disorder (ADHD)
- Autism
- Bipolar Disorder
- Combination Drug Dependence
- View All
Doctors Specialties
Accepted Insurances
Education
-
University of Kansas School of Medicine
-
University of the Witwatersrand
Hospital
-
The University of Kansas Hospital
-
Nationwide Children's Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER |
|
1497814545 |
| NPPES Provider LastName |
|
HELLINGS |
| NPPES Provider FirstName |
|
JESSICA |
| NPPES Provider ZIPCode |
|
430812890 |
| NPPES Provider State |
|
OH |
| Specialty Description |
|
Psychiatry |
| Total Claim Count |
|
663.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1497814545 |
| Last Name Of The Provider |
HELLINGS |
| First Name Of The Provider |
JESSICA |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.